Top Markets
#1 Black Phoenix Black Phoenix +733.82%
#2 MiL.k Alliance MiL.k Alliance +29.84%
#3 Biconomy Biconomy +24.27%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.03%
#5 THORChain THORChain +19.51%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +15.95%
#7 Moolah Moolah +14.73%
#8 THORChain Yield THORChain Yield +14.31%
#9 Tokamak Network Tokamak Network +12.76%
#10 XPIN Network XPIN Network +12.32%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Sam Chun Dang Pharm. Co., Ltd Sam Chun Dang Pharm. Co., Ltd

Sam Chun Dang Pharm. Co., Ltd

000250
Rank in Stocks #5349
Sam Chun Dang Pharm Co., Ltd. is a pharmaceutical company that develops and... Sam Chun Dang Pharm Co., Ltd. is a pharmaceutical company that develops and produces a wide variety of medications. Its product range features antibiotics, treatments for cardiovascular and respiratory conditions, drugs for the digestive system and ophthalmic use, as well as anti-inflammatory agents. The company was founded on December 29, 1943, and its main operations are based in Hwaseong-si, South Korea.
Share Price
$118.66
Market Cap
$2.78B
Change (1 day)
0.29%
Change (1 year)
-14.79%
Country
KR
Trade Sam Chun Dang Pharm. Co., Ltd (000250)

Category

Healthcare
Earnings for Sam Chun Dang Pharm. Co., Ltd (000250)
Earnings in 2026 TTM: 0
According to Sam Chun Dang Pharm. Co., Ltd latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Sam Chun Dang Pharm. Co., Ltd from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK